Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

Mesoblast Soars on Stem-Cell Treatment Data

By Armie Margaret Lee
Jul 5, 2017 10:37 AM EDT

These 5 Stocks Under $10 Could Explode Up Soon

By Roberto Pedone
Feb 9, 2017 2:03 PM EST

Today's Pre-Market Mover With Heavy Volume: Physicians Realty (DOC)

By TheStreet Wire
Dec 2, 2015 12:17 PM EST

Will Energy Transfer Equity (ETE) Stock Be Helped by Williams Partners Cost Cuts?

By Kurumi Fukushima
Jul 15, 2015 10:29 AM EDT

Insider Trading Alert - UVE, WETF And ENPH Traded By Insiders

By Brian Hamilton
Feb 25, 2015 1:00 PM EST

Insider Trading Alert - RYL, BHB And AAL Traded By Insiders

By Brian Hamilton
Dec 23, 2014 2:30 PM EST

3 Stocks Breaking Out on Unusual Volume

By Roberto Pedone
Mar 7, 2014 6:00 AM EST

Genfit Digs Even Deeper to Find Hidden Benefit in Fatty Liver Drug

By Adam Feuerstein
Feb 26, 2014 7:33 AM EST

Could This Biotech Stock Be First to Break Feuerstein-Ratain Rule?

By Adam Feuerstein
Jan 1, 2014 9:13 AM EST

Hedge Funds Love These 5 Consumer Stocks -- but Should You?

By Roberto Pedone
Oct 4, 2013 8:13 AM EDT

4 Big-Volume Stocks to Trade for Breakouts: Crocs, Rovi and More

By Roberto Pedone
Jul 19, 2013 7:12 AM EDT

Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie

By Adam Feuerstein
Jul 10, 2013 2:18 PM EDT

5 Stocks Under $10 Making Big Moves: Rex Energy, Corinthian Colleges and More

By Roberto Pedone
Jun 21, 2013 5:48 AM EDT

Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings

By Adam Feuerstein
Jun 14, 2013 7:00 AM EDT

Genfit Tortures Fatty Liver Drug to Extract Positive Results From Failed Study

By Adam Feuerstein
Jun 11, 2013 7:00 AM EDT

5 Dumbest Things on Wall Street

By Gregg Greenberg
Apr 26, 2013 7:00 AM EDT

Twitter Needs SoundCloud More Than the Reverse

By Gregg Greenberg
Apr 26, 2013 7:00 AM EDT

Steve Rosenman Says Amarin Has Sticky Web Eyeballs!

By Adam Feuerstein
Apr 23, 2013 5:11 PM EDT

Spectrum Pharma Implodes On Colossal Fusilev Sales Warning

By Adam Feuerstein
Mar 22, 2013 7:00 AM EDT

3 Stocks Breaking Out on Unusual Volume

By Roberto Pedone
Mar 8, 2013 7:00 AM EST

Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings

By Mark Messier
Mar 4, 2013 7:00 AM EST

Sangamo's HIV Gene Therapy Is a Valuation Prop, Nothing More

By Adam Feuerstein
Feb 15, 2013 6:30 AM EST

3 Unusual-Volue Stocks on the Rise

By Roberto Pedone
Feb 8, 2013 1:49 PM EST

Sangamo's HIV Gene Therapy Is a Valuation Prop, Nothing More

By Adam Feuerstein
Feb 5, 2013 10:05 AM EST

Early Amarin Vascepa Scripts Are Small, Hard To Interpret

By Adam Feuerstein
Feb 5, 2013 6:37 AM EST